Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 18, 2018 07:00 ET | Source: Belgravia Capital International

Belgravia Dermatology Completes Identification of Initial Drug Targets Within the Skin Endocannabinoid System and Also Identifies Bio Markers for Pre Clinical Work in Acne

TORONTO, June 18, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that its subsidiary, Belgravia Dermatology...
May 30, 2018 07:00 ET | Source: Belgravia Capital International

BELGRAVIA CAPITAL completes acquisition of interest in R&D Pharma Corp., a Canadian corporation building a vertically integrated medical cannabis business in Jamaica

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce that it has...
May 11, 2018 07:00 ET | Source: Belgravia Capital International

Belgravia Completes Transition of ICP Organics to Dermatology Product Development, Renames ICP Organics to Belgravia Dermatology Inc., and Appoints Sidney Himmel Director of Belgravia Dermatology

TORONTO, May 11, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) today announced that it has completed the strategic transition...
April 27, 2018 07:00 ET | Source: Belgravia Capital International

Belgravia Announces Results of Annual Meeting

TORONTO, April 27, 2018 (GLOBE NEWSWIRE) -- Belgravia Capital International Inc. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) is pleased to announce the results of the Company’s Annual...
April 18, 2018 07:00 ET | Source: Belgravia Capital International

Belgravia Appoints Dr. Sam Hanna Chief Medical Officer of Cannabis Dermatology Division

TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia” or the “Company”) has appointed Dr. Sam Hanna as Chief Medical Officer of its...
March 12, 2018 07:00 ET | Source: Belgravia Capital International

BELGRAVIA CAPITAL adds to expertise in corporate development and expands medical advisory committee

TORONTO, March 12, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce senior additions...
January 25, 2018 07:00 ET | Source: Belgravia Capital International

BELGRAVIA CAPITAL INTERNATIONAL and Fanlogic Commence Design of Blockchain Loyalty Program for the Global Cannabis Industry

TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
January 10, 2018 07:00 ET | Source: Belgravia Capital International

BELGRAVIA CAPITAL INTERNATIONAL receives cash payment, appoints renowned Dermatologist as special advisor to ICP Organics, and provides updates on additional blockchain developments

TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announced that the second...
January 04, 2018 07:00 ET | Source: Belgravia Capital International

BELGRAVIA CAPITAL INTERNATIONAL announces LOI with R&D Pharma Corp.

TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, “Belgravia”, or the “Company”) is pleased to announce the execution of...
December 05, 2017 09:03 ET | Source: Belgravia Capital International

BELGRAVIA CAPITAL Corporate Update

TORONTO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BELGRAVIA CAPITAL INTERNATIONAL INC. (CSE:BLGV) (OTCQB:BLGVF) (“Belgravia Capital”, or the “Company”) is pleased to comment on share price and trading...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right